Completed
A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
NCT01805375
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +22 more
- Locations
-
- Royal Liverpool and Broadgreen University Hospital NHS Trust Liverpool, United Kingdom
- The Christie NHS Foundation Trust Manchester, United Kingdom
- The Churchill Hospital Oxford, United Kingdom
- Derriford Hospital Plymouth, United Kingdom